Intravenous immunoglobulins for cutaneous polyarteritis nodosa resistant to conventional treatment

Scand J Rheumatol. 2016;45(2):169-70. doi: 10.3109/03009742.2015.1092582. Epub 2015 Nov 3.

Authors

L Breda¹, S Franchini¹, V Marzetti¹, F Chiarelli^{1

2}

Affiliations

¹ a Department of Paediatrics , University of Chieti , Italy.
² b Clinical Research Centre, Centre of Excellence on Ageing , 'G. D'Annunzio' University Foundation, University of Chieti , Italy.

PMID: 26526030
DOI: 10.3109/03009742.2015.1092582

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Azathioprine / therapeutic use
Child
Humans
Immunoglobulins, Intravenous / therapeutic use*
Immunosuppressive Agents / therapeutic use
Male
Pharyngitis / complications
Pharyngitis / drug therapy*
Polyarteritis Nodosa / complications
Polyarteritis Nodosa / drug therapy*
Prednisone / therapeutic use
Skin Diseases / complications
Skin Diseases / drug therapy*
Streptococcal Infections / complications
Streptococcal Infections / drug therapy*
Streptococcal Infections / microbiology
Streptococcus pyogenes
Treatment Failure

Substances

Immunoglobulins, Intravenous
Immunosuppressive Agents
Azathioprine
Prednisone